Name

GTX

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for GTX

Name

Alternate Names

LIT-976
RP-56976
Taxotere

Abbreviations

None

Category

Chemotherapy

Subcategory

Taxane

NSC Number

628503

Primary Site

Breast
gastric
head & neck
non-small cell lung
ovarian
prostate cancer

Histology

None

Remarks

FDA approved for use on breast, prostate, stomach and NSCLC. Aventis Pharmaceuticals.

Coding

This drug should be coded

Name

Alternate Names

Gemcitabine Hydrochloride
Gemzar
LY 188011
LY-188011
LY188011 hydrochloride
Gemcitabine HCL

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

613327

Primary Site

Bladder
Breast
non-small cell lung
ovarian
pancreatic cancer
Soft Tissue Sarcoma

Histology

None

Remarks

FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

Ro 091978
Ro-09-1978
Ro-091978
Xeloda

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

712807

Primary Site

Breast cancer
colorectal cancer

Histology

None

Remarks

FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.

Coding

This drug should be coded
Glossary